# Surmodics Inc. (SRDX)

Source: https://www.quantisnow.com/company/SRDX
Generated: 2026-11-11T20:10:22.200Z

- Ticker: SRDX
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Medical/Dental Instruments
- IPO year: 1998
- Website: surmodics.com

## About

Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. The company operates through two segments, Medical Device and In Vitro Diagnostics. The Medical Device segment engages in the provision of surface modification coating technologies to enhance access, deliverability, and predictable deployment of medical devices; and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device for coronary, peripheral, neuro-vascular and structural heart, and other markets, as well as design, development, and manufacturing of interventional medical devices, primarily balloons and catheters, including drug-coated balloons for peripheral arterial disease treatment and other applications. The Vitro Diagnostics segment designs, develops, and manufactures component products and technologies for diagnostic immunoassay, as well as molecular test and biomedical research applications. This segment offers protein stabilization reagents, substrates, surface coatings, and antigens. Surmodics, Inc. was founded in 1979 and is headquartered in Eden Prairie, Minnesota.

## Latest SRDX news and filings

- 2025-12-01 21:32 UTC [SEC Form 15-12G filed by Surmodics Inc.](https://www.quantisnow.com/insight/sec-form-15-12g-filed-by-surmodics-inc-6297962)
- 2025-11-21 05:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Surmodics Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-surmodics-inc-6289577)
- 2025-11-20 21:06 UTC [Amendment: SEC Form SCHEDULE 13D/A filed by Surmodics Inc.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13da-filed-by-surmodics-inc-6288756)
- 2025-11-19 23:18 UTC [SEC Form 4] [SVP, Medical Device Coatings Olson Charles W returned 52,278 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/svp-medical-device-coatings-olson-charles-w-returned-52278-shares-6287607)
- 2025-11-19 23:16 UTC [SEC Form 4] [VP Finance, Corp. Controller Manders John D. returned 8,155 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/vp-finance-corp-controller-manders-john-d-returned-8155-shares-6287604)
- 2025-11-19 23:15 UTC [SEC Form 4] [Sr. VP of Legal, GC and Sec. Weber Gordon S. returned 21,040 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/sr-vp-of-legal-gc-and-sec-weber-gordon-s-6287602)
- 2025-11-19 23:14 UTC [SEC Form 4] [SVP, Vascular Interventions Sides Teri Woodwick returned 34,703 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/svp-vascular-interventions-sides-teri-woodwick-returned-34703-shares-to-6287599)
- 2025-11-19 23:13 UTC [SEC Form 4] [Director Dantzker David returned 40,183 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/director-dantzker-david-returned-40183-shares-to-the-company-closing-6287598)
- 2025-11-19 23:11 UTC [SEC Form 4] [Director Heine Lisa Wipperman returned 13,978 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/director-heine-lisa-wipperman-returned-13978-shares-to-the-company-6287595)
- 2025-11-19 23:10 UTC [SEC Form 4] [Director Knight Susan E returned 37,240 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/director-knight-susan-e-returned-37240-shares-to-the-company-6287593)
- 2025-11-19 23:08 UTC [SEC Form 4] [Director Bedoya Jose H returned 30,008 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/director-bedoya-jose-h-returned-30008-shares-to-the-company-6287592)
- 2025-11-19 23:06 UTC [SEC Form 4] [Chief Financial Officer Arens Timothy J. returned 67,299 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/chief-financial-officer-arens-timothy-j-returned-67299-shares-to-6287589)
- 2025-11-19 23:04 UTC [SEC Form 4] [SVP of HR, President IVD Stich Joseph J. returned 61,631 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/svp-of-hr-president-ivd-stich-joseph-j-returned-61631-6287588)
- 2025-11-19 23:03 UTC [SEC Form 4] [President & CEO Maharaj Gary R returned 192,056 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/president-ceo-maharaj-gary-r-returned-192056-shares-to-the-6287587)
- 2025-11-19 21:48 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Surmodics Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-surmodics-inc-6287275)
- 2025-11-19 21:46 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Surmodics Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-surmodics-inc-6287268)
- 2025-11-19 21:45 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Surmodics Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-surmodics-inc-6287265)
- 2025-11-19 21:44 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Surmodics Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-surmodics-inc-6287247)
- 2025-11-19 21:39 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Surmodics Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-surmodics-inc-6287239)
- 2025-11-19 21:38 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Surmodics Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-surmodics-inc-6287234)
- 2025-11-19 21:37 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Surmodics Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-surmodics-inc-6287229)
- 2025-11-19 21:36 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Surmodics Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-surmodics-inc-6287218)
- 2025-11-19 21:35 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Surmodics Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-surmodics-inc-6287216)
- 2025-11-19 21:33 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Surmodics Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-surmodics-inc-6287202)
- 2025-11-19 21:32 UTC [SEC Form POS AM filed by Surmodics Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-surmodics-inc-6287187)
- 2025-11-19 21:30 UTC [SEC Form 8-K] [Surmodics Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Leadership Update](https://www.quantisnow.com/insight/surmodics-inc-filed-sec-form-8-k-completion-of-acquisition-or-6287150)
- 2025-11-17 11:00 UTC [Surmodics Announces FTC Does Not Intend to Appeal Denial of Injunction, Order Preventing Closing Set to Expire Today](https://www.quantisnow.com/insight/surmodics-announces-ftc-does-not-intend-to-appeal-denial-of-6281800)
- 2025-11-14 16:19 UTC [Analyst Downgrade] [Surmodics downgraded by Barrington Research](https://www.quantisnow.com/insight/surmodics-downgraded-by-barrington-research-6279599)
- 2025-11-12 11:15 UTC [SEC Form 8-K] [SEC Form 8-K filed by Surmodics Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-surmodics-inc-6272461)
- 2025-11-11 00:00 UTC [Surmodics Announces U.S. District Court Denies Request for Preliminary Injunction to Block Proposed Acquisition by GTCR](https://www.quantisnow.com/insight/surmodics-announces-us-district-court-denies-request-for-preliminary-injunction-6271642)
- 2025-11-04 11:15 UTC [Surmodics Announces Outcomes from 160 Patients in PROWL Registry Evaluating Pounce™ Thrombectomy Platform in Treatment of Real-World Limb Ischemia Presentations](https://www.quantisnow.com/insight/surmodics-announces-outcomes-from-160-patients-in-prowl-registry-evaluating-6257681)
- 2025-11-03 11:15 UTC [Surmodics Announces PROWL Registry 160-Patient Data to be Presented in Industry-Sponsored Session at VIVA Conference on November 3](https://www.quantisnow.com/insight/surmodics-announces-prowl-registry-160-patient-data-to-be-presented-in-6255221)
- 2025-10-29 20:15 UTC [Surmodics Announces Results from Sex-Specific Analysis of the PROWL Registry Study of Real-World Limb Ischemia Patients Treated with the Pounce™ Thrombectomy Platform](https://www.quantisnow.com/insight/surmodics-announces-results-from-sex-specific-analysis-of-the-prowl-registry-6250034)
- 2025-10-27 20:05 UTC [Surmodics Announces PROWL Registry Sex-Specific Data to be Presented at TCT Conference on October 28](https://www.quantisnow.com/insight/surmodics-announces-prowl-registry-sex-specific-data-to-be-presented-at-6245958)
- 2025-08-08 11:55 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Surmodics Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-surmodics-inc-6155438)
- 2025-08-08 11:00 UTC [SEC Form 8-K] [Surmodics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/surmodics-inc-filed-sec-form-8-k-results-of-operations-and-6155341)
- 2025-08-08 11:00 UTC [Earnings Date] [Surmodics Reports Third Quarter of Fiscal Year 2025 Financial Results; Updates Fiscal Year 2025 Financial Guidance](https://www.quantisnow.com/insight/surmodics-reports-third-quarter-of-fiscal-year-2025-financial-results-6155333)
- 2025-08-06 20:05 UTC [Earnings Date] [Surmodics to Report Third Quarter of Fiscal 2025 Financial Results on August 8](https://www.quantisnow.com/insight/surmodics-to-report-third-quarter-of-fiscal-2025-financial-results-6150313)
- 2025-07-15 15:55 UTC [SEC Form SCHEDULE 13G filed by Surmodics Inc.](https://www.quantisnow.com/insight/sec-form-schedule-13g-filed-by-surmodics-inc-6120365)
- 2025-07-02 11:00 UTC [SEC Form 8-K] [Surmodics Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/surmodics-inc-filed-sec-form-8-k-other-events-financial-statements-6107061)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/SRDX
- Earnings history: https://www.quantisnow.com/earnings/SRDX
- Dividend history: https://www.quantisnow.com/dividends/SRDX
- Insider transactions: https://www.quantisnow.com/insiders/SRDX
- Options chain: https://www.quantisnow.com/options/SRDX
- SEC 8-K filings only: https://www.quantisnow.com/company/SRDX/8-k
- RSS and alerts for SRDX: https://www.quantisnow.com/docs/rss-feeds.md